ONX-0914 (PR-957) TFA is a selective inhibitor of low-molecular mass polypeptide-7 (LMP7) , the chymotrypsin-like subunit of the immunoproteasome. ONX-0914 TFA blocks cytokine production and attenuates progression of experimental arthritis. ONX-0914 TFA iIn Vitro:ONX-0914 inhibits LMP7-specific antigen presentation. ONX-0914 blocks cytokine productionby mouse splenocytes and blocks T celldifferentiation. MCE has not independently confirmed the accuracy of these methods. They are for reference only.In Vivo:ONX-0914 (2-10mg/kg; i.v,; on days 4, 6 and 8) meliorates disease in mouse arthritis. ONX-0914 (2, 6 and 10 mg per kg body weight on days 25, 27, 29, 31 and 33; i.v.) treatment also induced a rapid therapeutic response in the T and B cell–dependentBiological Activity:ONX-0914 (PR-957) TFA is a selective inhibitor of low-molecular mass polypeptide-7 (LMP7) , the chymotrypsin-like subunit of the immunoproteasome. ONX-0914 TFA blocks cytokine production and attenuates progression of experimental arthritis. ONX-0914 TFA i.
Specifications and Purity: 10mM in DMSO
Molecular Formula: C33H41F3N4O9
Molecular Weight: 694.7
- UPC:
- 42201823
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- O661637-1ml
- Product Size:
- 1ml
akash.verma@cenmed.com
(732) 447-1115





